跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,031 条关于
“ELATIVE”
全部
7,031
临床试验
6,764
药物
35
机构
4
资讯
228
10个月前
IQIRVO Shows Sustained Long-Term Benefits in Primary Biliary Cholangitis with Novel Fatigue Mechanism Insights
去年
Elafibranor Demonstrates Improved Transplant-Free Survival in PBC Patients
2年前
Ipsen's Elafibranor Demonstrates Sustained Efficacy in Primary Biliary Cholangitis Phase III Trial
去年
Elafibranor Shows No Impact on Renal Function in Primary Biliary Cholangitis Patients
2年前
U.S. FDA Grants Priority Review for Elafibranor, a Potential New Treatment for Primary Biliary Cholangitis
去年
Iqirvo (Elafibranor) Shows Sustained Efficacy and Safety in Long-Term PBC Treatment
2年前
Elafibranor Shows Significant Efficacy in Phase III Trial for Primary Biliary Cholangitis
去年
Ipsen's Iqirvo Receives European Approval for Primary Biliary Cholangitis
去年
Ipsen's Iqirvo (elafibranor) Shows Sustained Efficacy and Safety in Long-Term PBC Treatment
2年前
Ipsen's Iqirvo Receives U.S. FDA Accelerated Approval for Primary Biliary Cholangitis Treatment
第 1 页,共 23 页
上一页
下一页